Table 4.
Reference | Image | Software | Endpoints | Sample Size (Training + Validation) | Results |
---|---|---|---|---|---|
Chu et al. [69] |
CT | Deeply supervised nets with encoder-decoder architecture | PDAC detection | 456 | Sensitivity = 94.1%, specificity = 98.5% |
Liu et al. [70] |
CT | CNN | Differentiating pancreatic cancer vs. normal pancreas | 295 + 691 (local test 1 + local test 2 + external test) | AUC = 0.997 (local test 1) AUC = 0.999 (local test 2) AUC = 0.920 (external test) |
Ozkan et al. [71] |
EUS | ANN with Relief-F feature reduction method | Pancreatic cancer diagnosis for different age groups | 260 + 72 | Age groups in years: <40, 40–60, >60: accuracy = 92%, 88.5%, 91.7%, respectively all age groups: accuracy = 87.5% |
Săftoiu et al. [72] |
EUS | ANN (MLP) | Differential diagnosis of chronic pancreatitis and pancreatic cancer | 68 (10-fold cross validation) | Benign vs. malignant pancreatic lesions: AUC = 0.957 Chronic pancreatitis vs. pancreatic cancer: AUC = 0.965 |
Săftoiu et al. [73] |
EUS | ANN (MLP) | Diagnosis of focal pancreatic masses | 258 (10-fold cross validation) | Average AUC = 0.94 over 100 runs of a complete cross-validation cycle |
Si et al. [74] |
CT | CNN ResNet18 (pancreas location), U-Net32 (pancreas segmentation), ResNet34 (pancreatic tumor diagnosis) |
Fully automated diagnosis of pancreatic tumors | 319 + 347 | AUC = 0.871 on testing for detection of all tumor types |
Tonozuka et al. [75] |
EUS | CNN | PDAC detection | 92 (10-fold cross validation) + 47 | AUC = 0.924 (cross validation) AUC = 940 (test) |
Zhang et al. [76] |
CT | Faster R-CNN combined with Feature Pyramid Network for feature extraction | Pancreatic tumor detection | 2650 + 240 (images) | AUC = 0.946 |
Abbreviations used in this table: Artificial Neural Network (ANN), Area Under Curve (AUC), Convolutional Neural Network (CNN), Multilayer Perceptron (MLP), Pancreatic Adenocarcinoma (PDAC).